NECTAR LIFESCIENCES
|
The Current P/E Ratio of NECTAR LIFESCIENCES is -1.68.
Share Price | ₹13.5 | Oct 15,2025 |
Market Cap | ₹302.8 Cr | |
Earnings-TTM | ₹-179.9 Cr | TTM-Consolidated Results |
Price/Earnings | -1.68x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of NECTAR LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹302.8 Cr] as on Oct 15,2025
(/) Earnings [ ₹-179.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -1.68x ]
Thus, for NECTAR LIFESCIENCES , the investors are currently willing to pay -1.68 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NECTAR LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of NECTAR LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of NECTAR LIFESCIENCES
PE Ratio Performance Analysis for NECTAR LIFESCIENCES
- NECTAR LIFESCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 31.34x.
- NECTAR LIFESCIENCES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NECTAR LIFESCIENCES 's p/e ratio peaked in Mar2024 at 135.18x.
- NECTAR LIFESCIENCES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does NECTAR LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
NECTAR LIFESCIENCES | -179.88 | -1.68 | 302.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.12 | 396,862.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 75.96 | 175,158.0 |
CIPLA LTD | 5,406.81 | 23.44 | 126,710.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 59.71 | 119,547.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.07 | 103,496.0 |
MANKIND PHARMA LTD | 1,905.51 | 52.98 | 100,948.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.20 | 98,339.2 |
LUPIN LTD | 3,722.18 | 23.81 | 88,643.6 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.79 | 64,222.1 |
ABBOTT INDIA LTD | 1,452.29 | 43.65 | 63,398.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs NECTAR LIFESCIENCES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -1.68x |
Max industry PE | 75.96x |
Median industry PE | 23.81x |
Average industry PE | 34.01x |
You may also like the below Video Courses